- Conditions
- Lymphoma, Acute Lymphoblastic Leukemia, Pediatric Cancer, Pediatric ALL, Pediatric Lymphoma
- Interventions
- Intravenous fluids
- Drug
- Lead sponsor
- Virginia Commonwealth University
- Other
- Eligibility
- 1 Year to 17 Years
- Enrollment
- 10 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2022
- U.S. locations
- 1
- States / cities
- Richmond, Virginia
Source: ClinicalTrials.gov public record
Updated Feb 12, 2024 · Synced May 22, 2026, 1:31 AM EDT